Enrolling by invitationNo phase
Study of people with REM sleep behavior disorder who may develop Parkinson disease
Enrolls people with a sleep disorder linked to Parkinson-type brain diseases to prepare future trials.
Plain-language title generated from the registry record
Registry title: North American Prodromal Synucleinopathy Consortium
Key facts
- Where
- Montreal, CanadaSee the site
Where in Canada
- McGill UniversityMontreal, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Washington University School of Medicine
- Trial code
- NCT03623672
- Record updated
- 6 November 2024
- Original description
This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.Read full original descriptionShow less
North American Prodromal Synucleinopathy Consortium
This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Inclusion: Idiopathic REM sleep behavior disorder.
Exclusion: REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc); Other neurological disorder.